For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 0 | 0* | 0 | 0 |
| Selling, general and administrative expenses | 253,019 | 1,392,780* | 207,845 | 187,373 |
| Research and development | 12,562 | 110,391.5* | 25,334 | 80,983 |
| Total operating expenses | 265,581 | 1,503,171.5* | 233,179 | 268,356 |
| Income/(loss) from operations | -265,581 | -1,503,171.5* | -233,179 | -268,356 |
| Interest expense | 48,109 | 29,608* | 30,684 | 25,100 |
| Interest expense - related party | 24,556 | 21,731* | 21,731 | 21,731 |
| Gain (loss) on derivative liabilities | 22,404 | 7,083.5* | - | - |
| Fraud loss | - | 220,749.5* | - | - |
| Gain (loss) on settlement of debt | - | 0* | 0 | 0 |
| Total other income (expense) | -50,261 | -265,005* | -52,415 | -46,831 |
| Income tax expense | - | 0* | - | - |
| Net income/(loss) | -315,842 | -1,768,176.5 | -285,594 | -315,187 |
| Diluted EPS | 0 | -0.007 | 0 | 0 |
| Diluted Average Shares | 258,690,253 | 255,994,431 | 257,809,759 | 257,139,815 |
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)